company background image
POLYMED logo

Poly Medicure NSEI:POLYMED 株式レポート

最終価格

₹1.99k

時価総額

₹178.5b

7D

9.0%

1Y

73.2%

更新

14 Jun, 2024

データ

会社財務 +

Poly Medicure Limited

NSEI:POLYMED 株式レポート

時価総額:₹178.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

POLYMED 株式概要

ポリメディキュア・リミテッドはインド国内および国際的に医療機器を製造・販売している。

POLYMED fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Poly Medicure Limited 競合他社

価格と性能

Summary of all time highs, changes and price drops for Poly Medicure
Historical stock prices
Current Share Price₹1,985.45
52 Week High₹1,925.60
52 Week Low₹1,075.00
Beta0.34
1 Month Change18.87%
3 Month Change38.57%
1 Year Change73.20%
3 Year Change120.68%
5 Year Change1,030.67%
Change since IPO5,429.54%

最新ニュース

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Recent updates

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

Mar 01
Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

Feb 16
I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Feb 01
How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Jan 17
Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 09
Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Nov 24
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Nov 09
Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Oct 26
Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Oct 06
Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Sep 17
Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Sep 02
Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

株主還元

POLYMEDIN Medical EquipmentIN 市場
7D9.0%2.4%3.7%
1Y73.2%58.9%44.7%

業界別リターン: POLYMED過去 1 年間で58.9 % の収益を上げたIndian Medical Equipment業界を上回りました。

リターン対市場: POLYMED過去 1 年間で43.8 % の収益を上げたIndian市場を上回りました。

価格変動

Is POLYMED's price volatile compared to industry and market?
POLYMED volatility
POLYMED Average Weekly Movement4.0%
Medical Equipment Industry Average Movement7.0%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.3%

安定した株価: POLYMEDの株価は過去 3 か月間にわたって変動しています。

時間の経過による変動: POLYMEDの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19952,339Himanshu Baidwww.polymedicure.com

ポリメディキュア・リミテッドは、インドおよび海外で医療機器を製造・販売している。輸液カニューレ、中間ラインカテーテル、動脈カニューレ、三方活栓、輸液セット、マニホールド、安全翼付き輸液セット、T型延長セット、ルアーロック付きスタイレット/マンドリン、バイアルアクセススパイク、定量輸液セット、延長ライン、中心静脈カテーテル、CVPマノメーター、ニードルフリーコネクター、プレフィルドシリンジ、バスキュラーアクセス、血液投与セットなどの輸液デバイスを提供している。また、経鼻胃管および乳児栄養チューブ、胃・十二指腸栄養チューブ、臍カテーテル、採尿バッグ、フォーリーバルーンカテーテル、灌流セット、導尿カテーテル、尿量測定器付き採尿バッグ、気管内・気管切開チューブ、粘液抽出器、人工呼吸器回路、ベイン回路、カテーテルマウント、脊髄針、HMEフィルター、喉頭マスクエアウェイも提供している。オンコロジー製品、気管支内吸引カテーテル、酸素カテーテル、呼吸運動器、経鼻酸素カニューレ、口腔咽頭エアウェイ、濃度可変マスク、リザーバー付き酸素マスク、固定濃度マスク、エアロゾル療法用マスク、ダイアライザー、血液ライン、透析システム、瘻孔針、血液透析カテーテル、腹膜透析・輸血セットを提供している。また、閉鎖創吸引装置、アンダーウォーターシールドドレナージシステム、高圧真空ボトル、ヤンカウアー吸引セット、胸腔ドレナージカテーテル、採血管、安全採血セット、採血針、ESRピペット、ルアーアダプターを提供している;血液バッグシステム、顔面保護シールド、ポリマスク、ウイルス輸送培地キット、インスリン注射器、喀痰コレクター、ドライブラシ、臍帯クランプ、ルアーロック、カニューレ固定器、注射ストッパー、ルアーロック注射部位、ユニバーサルキャップ、心電図電極。同社は1995年に設立され、インドのニューデリーを拠点としている。

Poly Medicure Limited 基礎のまとめ

Poly Medicure の収益と売上を時価総額と比較するとどうか。
POLYMED 基礎統計学
時価総額₹178.52b
収益(TTM)₹2.58b
売上高(TTM)₹13.76b

73.6x

PER(株価収益率

13.8x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
POLYMED 損益計算書(TTM)
収益₹13.76b
売上原価₹4.83b
売上総利益₹8.93b
その他の費用₹6.35b
収益₹2.58b

直近の収益報告

Mar 31, 2024

次回決算日

該当なし

一株当たり利益(EPS)26.91
グロス・マージン64.92%
純利益率18.77%
有利子負債/自己資本比率11.6%

POLYMED の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

0.2%

現在の配当利回り

11%

配当性向